334 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Unknown  Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Intervention: Drug: Bevacizumab (Avastin), Verteporfin (Visudyne)
22 Recruiting Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Condition: Exudative Age-related Macular Degeneration
Interventions: Drug: 24GyE proton and Anti-VEGF;   Drug: 16GyE and anti-VEGF;   Drug: Sham Irradiation and anti-VEGF
23 Recruiting Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
24 Unknown  A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ALG 1001
25 Recruiting Photodynamic Therapy for PDA in NV AMD
Conditions: Neovascular Age-related Macular Degeneration;   Macular Degeneration
Intervention: Other: No Intervention
26 Recruiting Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
Condition: Dry Macular Degeneration
Intervention: Biological: Adipose Derived Stem Cells
27 Not yet recruiting Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
Condition: Wet Age-related Macular Degeneration
Interventions: Drug: Bevacizumab;   Drug: Ranibizumab
28 Unknown  Intravitreal Bevacizumab for Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: bevacizumab intravitreal injection
29 Recruiting S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Conditions: Cataract;   Macular Degeneration
Interventions: Drug: selenium;   Drug: vitamin E;   Drug: vitamin E placebo;   Drug: selenium placebo
30 Recruiting Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
Condition: Age Related Macular Degeneration and Stargartd
Intervention: Other: intravitreal injection of autologous bone marrow stem cells
31 Recruiting Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration
Conditions: Depression;   Age-related Macular Degeneration
Intervention: Behavioral: Self-Care Tools
32 Recruiting A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: DE-120;   Drug: Aflibercept
33 Unknown  Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
34 Recruiting Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
Condition: Age-related Macular Degeneration
Intervention:
35 Recruiting A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
Conditions: Diabetic Macular Edema;   Age-related Macular Degeneration
Intervention: Drug: MTP-131
36 Recruiting Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Monthly Ranibizumab Injections
Condition: Age Related Macular Degeneration
Intervention: Drug: Aflibercept
37 Recruiting Non-exudative Age-related Macular Degeneration
Condition: Non-exudative Age-related Macular Degeneration
Intervention:
38 Recruiting Time to Treatment Utilizing a Tele-Retinal Referral System for Wet Age Related Macular Degeneration and Diabetic Macular Edema: A Pilot Study
Conditions: Wet Age Related Macular Degeneration;   Diabetic Macular Edema
Intervention:
39 Recruiting A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
Condition: Wet Age-related Macular Degeneration
Intervention:
40 Not yet recruiting Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)
Condition: Stage 3 Age Related Macular Degeneration (AREDS Classification)
Intervention: Device: MAIA™ (Centrevue, Padova, Italy; distributed in France by EDC Lamy, Carvin, France)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years